DMT Study Set To Explore Breakthrough Potential in Stroke Recovery
Source: Streetwise Reports (02/14/2025)
Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) subsidiary Algernon NeuroScience has appointed Dr. Sandor Nardai as Principal Investigator for its upcoming Phase 2a DMT stroke study. Find out how this trial could reshape stroke recovery research.
read more >
Kentucky Medical Co. Has Strong Operating Fundamentals
Source: Douglas Loe (02/12/2025)
Quipt Home Medical Corp. (QIPT:NASDAQ; QIPT:TSX.V) received a lowered price target but a Buy rating from a Leede Financial Inc. research note.
read more >
AI Stock in an Uptrend That Is Likely To Continue
Source: Clive Maund (02/10/2025)
Technical Analyst Clive Maund explains why he thinks Light AI Inc. (ALGO:CBOE) is an Immediate Strong Buy.
read more >
Biotech Requests OK to Assess Device in Second Indication
Source: Dr. Joseph Pantginis (02/06/2025)
The company behind this possible "pipeline in a device" wants to evaluate it now in thyroid disease after having begun with trials in type 1 diabetes, noted an H.C. Wainwright & Co. report.
read more >
Healthcare Pioneer Expands Revolutionary Treatment Platform
Source: Streetwise Reports (02/06/2025)
Leading regenerative medicine company Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) says it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its Cell Pouch technology. One analyst says it is the "most advanced encapsulation device in development."
read more >